The First Use of Live Continuous Glucose Monitoring in Patients on Extracorporeal Life Support

Javid, Patrick J.; Halwick, David R.; Betit, Peter; Thompson, John E.; Long, Kenny; Zhang, Yanan; Jaksic, Tom; Agus, Michael S. D.

doi:10.1089/dia.2005.7.431

Cited by 18 publications

(9 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Finally, higher plasma glucose levels and a higher glucose turnover have been described when lactate-based solutions are employed [30]. It remains unclear whether or not glucose losses should be compensated, but current evidence suggests that keeping glycemia within normal range is beneficial [31]. …”

Section: Adverse Events Related To Rrtmentioning

confidence: 99%

Handling Continuous Renal Replacement Therapy-Related Adverse Effects in Intensive Care Unit Patients: The Dialytrauma Concept

Moliner¹,

Honoré²,

Riera³

et al. 2012

Blood Purif

View full text Add to dashboard Cite

Continuous renal replacement therapy (CRRT) is increasingly used for the management of critically ill patients. As a consequence, the incidence of complications that accompany CRRT is also rising. However, a standardized approach for preventing or minimizing these adverse events is lacking. Dialytrauma is a newly proposed concept that encompasses all harmful adverse events related to CRRT while providing a framework for prevention or, at the least, early recognition of these events in order to attenuate the consequences. A mainstay of this approach is the utilization of a dedicated checklist for improving CRRT quality and patient safety. In this context, we discuss the most important adverse effects of CRRT and review current strategies to minimize them.

show abstract

Section: Adverse Events Related To Rrtmentioning

confidence: 99%

Handling Continuous Renal Replacement Therapy-Related Adverse Effects in Intensive Care Unit Patients: The Dialytrauma Concept

Moliner¹,

Honoré²,

Riera³

et al. 2012

Blood Purif

View full text Add to dashboard Cite

show abstract

“…Only a few studies applied CGM in critically ill patients [6,34,37,[128][129][130][131][132][133][134][135]. In a pilot study we investigated the accuracy and applicability of continuous glucose monitoring (GlucoDay ® , A. Menarini Diagnostics, Florence, Italy) in the medical ICU.…”

Section: Technical Requirements and Validation For The Icumentioning

confidence: 99%

“…An Extracorporeal Glucose Monitoring System (EGMS ® , Medtronic Minimed, Northridge, CA) was tested in patients on extracorporeal bypass [132]. It demonstrated a 7-10 min lag of EGMS glucose values in conditions of fast changing glycemia.…”

Section: Technical Requirements and Validation For The Icumentioning

confidence: 99%

Glucose Control and Use of Continuous Glucose Monitoring in the Intensive Care Unit: A Critical Review

Block

Manuel-y-Keenoy²,

Rogiers³

et al. 2008

CDR

View full text Add to dashboard Cite

Stress hyperglycemia recently became a major therapeutic target in the Intensive Care Unit (ICU) since it occurs in most critically ill patients and is associated with adverse outcome, including increased mortality. Intensive insulin therapy to achieve normoglycemia may reduce mortality, morbidity and the length of ICU and in-hospital stay. However, obtaining normoglycemia requires extensive efforts from the medical staff, including frequent glucose monitoring and adjustment of insulin dose. Current insulin titration is based upon discrete glucose measurements, which may miss fast changes in glycemia and which does not give a full picture of overall glycemic control. Recent evidence suggests that continuous monitoring of glucose levels may help to signal glycemic excursions and eventually to optimize insulin titration in the ICU. In this review we will summarise monitoring and treatment strategies to achieve normoglycemia in the ICU, with special emphasis on the possible advantages of continuous glucose monitoring.

show abstract

“…Special attention is needed when nutrition (in particular enteral nutrition) is withdrawn in case of hypoglycemia because glucose is easily removed from the plasma. In the future, continuous glucose monitoring in patients on extracorporeal treatment, including CRRT, may be the best option to anticipate for dysglycemia problems [21]. …”

Section: Specific Nutritional Compoundsmentioning

confidence: 99%

Nutritional and Metabolic Alterations during Continuous Renal Replacement Therapy

Honoré

Waele²,

Jacobs³

et al. 2013

Blood Purif

View full text Add to dashboard Cite

Adequate feeding of critically ill patients under continuous renal replacement therapy (CRRT) remains a challenging issue. We performed a systematic search of the literature published between 1992 and 2012 using the quorum guidelines regarding nutrition in intensive care unit patients treated with CRRT. Daily recommended energy requirements during CRRT are between 25 and 35 kcal/kg with carbohydrates and lipids accounting for 60-70% and 30-40% of calorie intake, respectively. Daily protein needs range from 1.5 to 1.8 g/kg. Indirect calorimetry corrected for CRRT-induced CO₂ diversion should be used to more correctly match calorie intake to the real needs. This type of tool is not yet available but hopefully soon. Electrolyte deficit as well as overload have been described during CRRT but, in general, can be easily controlled. Although not strongly evidenced, consensus exists to supplement important micronutrients such as amino acids (glutamine), water-soluble vitamins and trace elements.

show abstract

The First Use of Live Continuous Glucose Monitoring in Patients on Extracorporeal Life Support

Cited by 18 publications

References 9 publications

Handling Continuous Renal Replacement Therapy-Related Adverse Effects in Intensive Care Unit Patients: The Dialytrauma Concept

Handling Continuous Renal Replacement Therapy-Related Adverse Effects in Intensive Care Unit Patients: The Dialytrauma Concept

Glucose Control and Use of Continuous Glucose Monitoring in the Intensive Care Unit: A Critical Review

Nutritional and Metabolic Alterations during Continuous Renal Replacement Therapy

Contact Info

Product

Resources

About